Federal contractor profile

VITRUVIAN BIO, LLC

UEI JHJJANE1ALC6CAGE 8L4Z5

Active
Woman Owned Small BusinessWoman Owned BusinessSmall Business

Overview

Legal name
VITRUVIAN BIO, LLC
Registered location
BALTIMORE, MD, USA
Primary NAICS
541713 — Research and Development in Nanotechnology
Latest award activity
Jun 25, 2025
Read company summary

VITRUVIAN BIO, LLC is associated with UEI JHJJANE1ALC6 and CAGE 8L4Z5 in public federal records. AcornBids currently links 2 prime awards totaling $600.0K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541713 (Research and Development in Nanotechnology). Its public SAM.gov registration lists BALTIMORE, MD, USA.

At a glance

Lifetime prime obligations$600.0K
Prime awards2
Awards with future end dates0
Top-agency concentration100.0%

Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 6, 2026. Refresh pending; these totals may be out of date.

Business information

Public SAM.gov registration details.

Legal name
VITRUVIAN BIO, LLC
UEI
JHJJANE1ALC6
CAGE
8L4Z5
Registered address
7 SAINT PAUL ST STE 1500, BALTIMORE, MD, 21202, USA
Registration status
Active
Primary NAICS
541713 — Research and Development in Nanotechnology
SAM activation
Mar 25, 2026
Initial registration
Jan 25, 2023
Entity start
Apr 22, 2020
SAM updated
Mar 25, 2026
Registration expires
Mar 23, 2027
Fiscal year end
Dec 31
Place of incorporation
MD, USA

View SAM.gov source

Research brief

Source facts

  • Loaded prime-award records link 2 awards and $599,967 in reported obligations to this legal entity. Source
  • Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
  • An example award describes: AN ELECTROCHEMICAL SELF-MONITORING DEVICE FOR RAPID NUCLEIC ACID BASED TESTING OF HIV-1 Source

Federal award analysis

Net transaction obligations by federal fiscal period.

Selected transaction obligations$300.0K
Prime contracts

Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 2 of 2 selected awards. Select a period to explore its awards.

Funding change

Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.

MeasureReported value
Current periodOct 1, 2025 – Sep 30, 2026
Current obligationsNot reported
Prior periodOct 1, 2024 – Sep 30, 2025
Prior obligations$0
ChangeNot reported
GrowthNot comparable

Where the work is performed

AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL

State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.

Agencies
CategoryPeriod obligationsAwards
Department of Health and Human Services$300.0K2
Offices
Naics
Psc
Vehicles
CategoryPeriod obligationsAwards
Unclassified$300.0K2
States
CategoryPeriod obligationsAwards
MD$300.0K2
Set Asides
CategoryPeriod obligationsAwards
SMALL BUSINESS SET ASIDE - TOTAL$300.0K2

Recent federal awards

Prime contract awards. Select an award to review its history and source evidence.

Award / descriptionAwarding agencyObligationsStart dateEnd date
75N93024C00042AN ELECTROCHEMICAL SELF-MONITORING DEVICE FOR RAPID NUCLEIC ACID BASED TESTING OF HIV-1Department of Health and Human Services$300.0KAug 1, 2024Apr 14, 2025
75N95024C00040NIMH SBIR PHASE 1 TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYSDepartment of Health and Human Services$300.0KSep 23, 2024Sep 22, 2025

Registration, certifications & contacts

Registration evidenceDate
SAM updatedMar 25, 2026
Source loadedSep 26, 2026
Initial registrationJan 25, 2023
Entity startApr 22, 2020

Registration classifications: Self Certified Small Disadvantaged Business, Woman Owned Small Business, Woman Owned Business, Small Business. These are separate from the reported certificates above.

IndustryReported size status
541713 — Research and Development in NanotechnologyNot reported
541714 — Research and Development in Biotechnology (except Nanobiotechnology)Not reported
ContactRolePublished contact methodsEvidenceSource date
ANGANA SENPANGovernment businessContact method not publishedSAM registrationNot available
ANGANA SENPANElectronic businessContact method not publishedSAM registrationNot available
Registered industries
  • 541713 — Research and Development in Nanotechnology
  • 541714 — Research and Development in Biotechnology (except Nanobiotechnology)

Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source

Related companies worth researching

Explore the customer, work and award-size evidence behind each match.

TEXAS A&M AGRILIFE RESEARCH

1 shared agency customer(s); Shared work: 541714 — Research and Development in Biotechnology (except Nanobiotechnology), 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

LOVELACE BIOMEDICAL RESEARCH INSTITUTE

1 shared agency customer(s); Shared work: 541714 — Research and Development in Biotechnology (except Nanobiotechnology), 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

DUKE UNIVERSITY

1 shared agency customer(s); Shared work: 541714 — Research and Development in Biotechnology (except Nanobiotechnology), 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Average reported award size within 0.5–2× in matching records. Counts and amounts describe sampled matching awards, not the company’s full history.
2 awards

10X GENOMICS, INC.

1 shared agency customer(s); Shared work: 541714 — Research and Development in Biotechnology (except Nanobiotechnology), 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Counts and amounts describe sampled matching awards, not the company’s full history.
9 awards

THE JOHNS HOPKINS UNIVERSITY

1 shared agency customer(s); Shared work: 541714 — Research and Development in Biotechnology (except Nanobiotechnology), 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Counts and amounts describe sampled matching awards, not the company’s full history.
7 awards

REGENTS OF THE UNIVERSITY OF MICHIGAN

1 shared agency customer(s); Shared work: 541714 — Research and Development in Biotechnology (except Nanobiotechnology), 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Counts and amounts describe sampled matching awards, not the company’s full history.
3 awards
Data coverage and methodology

Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.

Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.

Keep your research moving

Save this company, track changes, and evaluate upcoming work against your targets.

Save to my research Find my fit